financetom
Business
financetom
/
Business
/
Universal Insurance Holdings Insider Sold Shares Worth $526,806, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Universal Insurance Holdings Insider Sold Shares Worth $526,806, According to a Recent SEC Filing
May 26, 2025 9:53 AM

05:48 PM EDT, 05/16/2025 (MT Newswires) -- Sean P Downes, Director, Executive Chairman, on May 16, 2025, sold 20,000 shares in Universal Insurance Holdings ( UVE ) for $526,806. Following the Form 4 filing with the SEC, Downes has control over a total of 971,667 common shares of the company, with 951,667 shares held directly and 20,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/891166/000089116625000067/xslF345X05/wk-form4_1747431739.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lumen Technologies Refinances Debt, Extends Maturity
Lumen Technologies Refinances Debt, Extends Maturity
Mar 27, 2025
05:16 PM EDT, 03/27/2025 (MT Newswires) -- Lumen Technologies ( LUMN ) late Thursday said its subsidiary, Level 3 Financing, has refinanced its existing term loans with a new $2.4 billion term loan maturing in 2032. The new loan is priced at a term secured overnight financing rate plus 4.25% and extends the maturity of Level 3's debt by 30...
Hims & Hers Health Insider Sold Shares Worth $2,358,145, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $2,358,145, According to a Recent SEC Filing
Mar 27, 2025
05:06 PM EDT, 03/27/2025 (MT Newswires) -- Melissa Baird, Chief Operating Officer, on March 26, 2025, sold 67,687 shares in Hims & Hers Health ( HIMS ) for $2,358,145. Following the Form 4 filing with the SEC, Baird has control over a total of 751,243 Class A common shares of the company, with 751,243 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000106/xslF345X05/wk-form4_1743109451.xml...
Portage Reports 'Promising' Preclinical Results in Mesothelioma
Portage Reports 'Promising' Preclinical Results in Mesothelioma
Mar 27, 2025
05:11 PM EDT, 03/27/2025 (MT Newswires) -- Portage Biotech ( PRTG ) reported late Thursday encouraging efficacy data in a murine mesothelioma model with PORT-7 given as a single agent or in combination with anti-PD-1 antibody. The data showed both single agent activity, and more than 90% inhibition of tumor growth when PORT-7 was combined with an anti-PD1 antibody in...
Beam Therapeutics New Drug Application for Alpha-1 Antitrypsin Deficiency Gets FDA Clearance
Beam Therapeutics New Drug Application for Alpha-1 Antitrypsin Deficiency Gets FDA Clearance
Mar 27, 2025
05:10 PM EDT, 03/27/2025 (MT Newswires) -- Beam Therapeutics ( BEAM ) said Thursday the US Food and Drug Administration cleared its investigational new drug application for BEAM-302 to treat alpha-1 antitrypsin deficiency, an genetic disorder that affects lungs or liver. Earlier this month, Beam disclosed initial safety and efficacy data from a global phase 1/2 study, showcasing the first...
Copyright 2023-2026 - www.financetom.com All Rights Reserved